Sherwin-Williams
SHW
$319.91
+0.46%
The Sherwin-Williams Company is the world's largest manufacturer of paints and coatings, serving professional painters, contractors, industrial manufacturers, and DIY consumers through its Paint Stores Group, Consumer Brands Group, and Performance Coatings Group. As a dominant market leader with over 4,800 company-owned stores and a strong brand presence at retailers like Lowe's, Sherwin-Williams benefits from a vast distribution network and deep customer relationships. The current investor narrative centers on the company's ability to sustain mid-single-digit revenue growth amid a mixed macroeconomic environment, with attention on margin resilience, disciplined capital allocation, and the potential for further market share gains in the fragmented coatings industry.…
SHW
Sherwin-Williams
$319.91
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating: Hold. Thesis: Sherwin-Williams is a high-quality market leader with accelerating revenue growth and strong cash flows, but its premium valuation and high leverage limit upside potential, making it a hold for current investors and a cautious buy for new ones. Analyst consensus is Buy with an average target of $378.90, implying 14.4% upside.
Supporting Evidence: Revenue grew 6.81% YoY in Q1 2026 to $5.667 billion, with gross margin expanding to 49.07%. Free cash flow TTM is $2.905 billion, supporting a dividend yield of 0.99% with a 30.7% payout ratio. The forward P/E of 24.97x is lower than the trailing 31.22x, implying expected earnings growth. However, the PEG ratio is negative (-11.11x), and the stock trades at a premium to industry average P/E of 15-20x. The average analyst target of $378.90 offers upside, but the low target of $330.00 is near the current price, indicating downside risk.
Risks & Conditions: The biggest risks are high debt (D/E 3.16), premium valuation, and macro sensitivity. This Hold would upgrade to Buy if the stock pulls back to $300 (trailing P/E ~24x) or if revenue growth accelerates above 10%. It would downgrade to Sell if gross margins fall below 45% or if the company cuts its dividend. Overall, SHW is fairly valued relative to its history (P/E range 19-44x) but overvalued versus industry peers, warranting a cautious stance.
Sign up to view all
SHW 12-Month Price Forecast
The outlook for SHW over the next 12 months is balanced. The company's accelerating revenue growth and strong free cash flow provide a solid foundation, but the premium valuation and high leverage limit upside potential. The base case of 5-7% growth and stable margins is most likely, supporting a price near the analyst average of $378.90. However, the bear case of a housing downturn could push the stock to $290. The neutral stance reflects the tension between quality fundamentals and elevated valuation. An upgrade to bullish would require evidence of sustained margin expansion or a pullback to a more attractive entry point, while a downgrade to bearish would follow a deterioration in end-market demand or a credit event.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $379.60 and implied upside of +18.7% versus the current price.
Average Target
$379.60
0 analysts
Implied Upside
+18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$330 - $420
Analyst target range
The stock is covered by 20 analysts, with a consensus recommendation of 'Buy' (mean recommendation 2.04 on a 1-5 scale where 1 is strong buy). The average target price is $378.90, implying approximately +14.4% upside from the current price of $331.32. The distribution leans bullish, with recent ratings from RBC Capital, BMO Capital, Citigroup, and Evercore ISI all at Outperform or Buy, while UBS downgraded to Neutral in June 2026. The target price range spans from $330.00 (low) to $420.00 (high). The high target of $420.00 assumes continued market share gains, margin expansion, and potential multiple expansion, while the low target of $330.00 prices in slower growth or margin compression. The spread between low and high ($90) is moderate, indicating some uncertainty but reasonable conviction. Recent analyst actions show mostly reaffirmations, with only UBS downgrading, suggesting overall positive sentiment. The wide range reflects differing views on the pace of recovery in end markets and the impact of raw material costs.
Bulls vs Bears: SHW Investment Factors
Sherwin-Williams presents a mixed picture: its dominant market position, accelerating revenue growth, and strong free cash flow generation are compelling bull arguments, supported by analyst consensus Buy and 14.4% upside. However, the stock carries significant leverage (D/E 3.16), has underperformed the market by over 20% in the past year, and trades at a premium valuation (trailing P/E 31.22x) relative to industry peers. The single most important tension is whether the company can sustain its mid-single-digit revenue growth and margin resilience to justify its premium multiple, or if macroeconomic headwinds and high debt will lead to earnings disappointment and further multiple compression. Currently, the bull case has slightly stronger evidence given the accelerating growth and analyst support, but the bear risks are substantial and warrant caution.
Bullish
- Dominant Market Position: Sherwin-Williams is the world's largest paint manufacturer with over 4,800 company-owned stores, providing a vast distribution network and deep customer relationships that drive market share gains in a fragmented industry.
- Accelerating Revenue Growth: Q1 2026 revenue grew 6.81% YoY to $5.667 billion, accelerating from prior quarters, indicating strong demand and successful market share expansion.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $2.905 billion, providing ample capacity for dividends, share repurchases, and debt reduction, supporting shareholder returns.
- Analyst Consensus Buy with Upside: 20 analysts rate the stock a Buy with an average target of $378.90, implying +14.4% upside from the current price of $331.32, reflecting confidence in future performance.
Bearish
- High Debt-to-Equity Ratio: Debt-to-equity stands at 3.16, indicating significant leverage that could strain finances if interest rates remain elevated or earnings decline, increasing financial risk.
- Underperformance vs. S&P 500: Over the past year, SHW returned -2.52% versus the S&P 500's +18.35%, a relative underperformance of over 20 percentage points, suggesting negative market sentiment.
- Premium Valuation vs. Peers: Trailing P/E of 31.22x is above the specialty chemicals industry average of 15-20x, leaving little room for error and making the stock vulnerable to multiple compression.
- Negative PEG Ratio: PEG ratio of -11.11x indicates negative earnings growth expectations, which is a red flag for a growth-oriented valuation, potentially signaling overvaluation.
SHW Technical Analysis
The stock is in a broad downtrend over the past year, with a 1-year price change of -2.52%, significantly underperforming the S&P 500's +18.35% gain. The current price of $331.32 sits at 76% of its 52-week range ($289.86 low to $379.65 high), indicating it is closer to the lower end of the range. This positioning suggests the stock has been under pressure and may be viewed as a value opportunity, but the downtrend warrants caution as it could also reflect deteriorating fundamentals. Over the last 1 month, the stock has rallied 5.58%, while the 3-month change is -4.12%, showing a recent short-term bounce that contrasts with the longer-term decline. This divergence could signal a potential trend reversal or a temporary pullback within a larger downtrend. The 1-month relative strength of +5.27% versus the S&P 500 suggests near-term momentum is improving, but the 3-month relative strength of -8.79% confirms the intermediate-term weakness. The 52-week low of $289.86 provides key support, while the 52-week high of $379.65 acts as resistance. A breakout above $379.65 would signal a strong reversal, while a breakdown below $289.86 could accelerate selling. With a beta of 1.1, the stock is slightly more volatile than the market, meaning it may amplify broader market moves, which is important for risk management.
Beta
1.10
1.10x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$290-$380
Price range past year
Annual Return
-5.9%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | +0.9% | +0.4% |
| 3m | -5.3% | +5.5% |
| 6m | -8.2% | +8.4% |
| 1y | -5.9% | +18.9% |
| ytd | -2.4% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue in the most recent quarter (Q1 2026) was $5.667 billion, up 6.81% year-over-year from $5.306 billion in Q1 2025, indicating accelerating growth. The multi-quarter trend shows revenue growing from $5.297 billion (Q4 2024) to $6.162 billion (Q3 2025) and $6.314 billion (Q2 2025), though Q1 2026 is seasonally lower. The Paint Stores Group contributed $3.050 billion, Consumer Group $2.186 billion, and Global Finishes Group $1.719 billion, with the Paint Stores segment driving the bulk of growth. This growth trajectory supports the investment case, as Sherwin-Williams continues to gain share in a fragmented market. The company is profitable, with net income of $534.7 million in Q1 2026 and a gross margin of 49.07%, which is relatively stable compared to 48.23% in Q1 2025. Operating margin improved to 14.31% from 14.22% a year ago, while net margin was 9.44% versus 9.50% in Q1 2025, showing slight compression. The company has maintained healthy margins despite cost pressures, which is typical for the specialty chemicals industry where gross margins often range 40-50%. Sherwin-Williams has a debt-to-equity ratio of 3.16, indicating significant leverage, but it generated $2.905 billion in free cash flow over the trailing twelve months. The ROE is exceptionally high at 55.86%, reflecting efficient use of equity, though this is partly due to high leverage. The current ratio of 0.87 suggests tight liquidity, but strong operating cash flow of $1.391 billion in Q1 2026 provides ample coverage for debt service and capital expenditures of $138.3 million. The company's ability to generate substantial free cash flow supports its dividend and share repurchase programs, reducing reliance on external financing.
Quarterly Revenue
$5.7B
2026-03
Revenue YoY Growth
+6.8%
YoY Comparison
Gross Margin
49.1%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 31.22x, while the forward P/E is 24.97x, implying the market expects earnings growth over the next year. The gap between trailing and forward P/E suggests analysts anticipate a 20% earnings increase, which is optimistic given the current growth rate. Compared to the industry average (not provided, but specialty chemicals typically trade at 15-20x P/E), Sherwin-Williams' trailing P/E of 31.22x appears at a premium. The stock's P/S ratio of 3.39x is also above the sector median, reflecting a premium for its market leadership and brand strength. Historically, the stock's trailing P/E has ranged from about 19x to 44x over the past five years (based on historical ratios data). The current 31.22x is near the middle of that range, suggesting it is not extremely overvalued or undervalued relative to its own history. The PEG ratio is negative (-11.11x) due to negative earnings growth expectations, which is a red flag, but this may be distorted by one-time items. Overall, the valuation appears fair, with the premium justified by Sherwin-Williams' dominant market position and consistent cash generation.
PE
31.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Sherwin-Williams carries a high debt-to-equity ratio of 3.16, which amplifies earnings volatility and interest expense sensitivity. In Q1 2026, interest expense was $131.6 million, consuming about 24.6% of operating income. The current ratio of 0.87 indicates tight liquidity, though strong operating cash flow of $1.391 billion in Q1 2026 provides near-term coverage. Net margin slightly compressed from 9.50% to 9.44% YoY, suggesting cost pressures. Revenue concentration in the Paint Stores Group (53.8% of Q1 2026 revenue) exposes the company to housing market cycles and professional painter demand.
Market & Competitive Risks: The stock's beta of 1.1 indicates slightly higher market sensitivity, and its trailing P/E of 31.22x is at a premium to the specialty chemicals industry average of 15-20x, making it vulnerable to valuation compression if growth disappoints. The 1-year relative strength of -20.87% versus the S&P 500 shows persistent underperformance, which could continue if macro conditions worsen. Competitive threats from PPG Industries and Axalta Coating Systems, along with potential raw material cost inflation, could pressure margins. The UBS downgrade to Neutral in June 2026 highlights emerging skepticism.
Worst-Case Scenario: A severe housing downturn combined with rising raw material costs and higher interest rates could compress margins and reduce demand, leading to earnings misses. The stock could fall to its 52-week low of $289.86, representing a -12.5% decline from the current price of $331.32. In a more extreme scenario, if the company cuts its dividend or faces a credit downgrade, the stock could test the $250 level, implying a -24.5% loss. The historical max drawdown of -21.91% suggests such a decline is within the realm of possibility.
FAQ
The key risks are: 1) Financial risk from high leverage (D/E 3.16) and tight liquidity (current ratio 0.87), which could strain earnings if interest rates stay high. 2) Valuation risk from a premium P/E (31.22x) that could compress if growth disappoints. 3) Macro risk from housing market sensitivity, as a downturn could reduce paint demand. 4) Competitive risk from rivals like PPG and Axalta. The most severe risk is a recession causing earnings to fall, potentially driving the stock to its 52-week low of $289.86 (-12.5% from current price).
The 12-month forecast is mixed. The base case (50% probability) expects revenue growth of 5-7% and stable margins, with the stock trading near the analyst average target of $378.90 (14.4% upside). The bull case (25% probability) sees stronger growth and multiple expansion to $420 (26.8% upside). The bear case (25% probability) involves a housing downturn and margin compression, driving the stock to $289.86 (12.5% downside). The most likely scenario is the base case, supported by accelerating revenue growth and analyst optimism, but the high debt and premium valuation cap upside.
SHW's trailing P/E of 31.22x is above the specialty chemicals industry average of 15-20x, suggesting it is overvalued relative to peers. However, compared to its own historical range of 19-44x over the past five years, the current multiple is near the middle, indicating it is fairly valued relative to its own history. The forward P/E of 24.97x implies expected earnings growth, but the negative PEG ratio (-11.11x) raises concerns about growth sustainability. The market is pricing in a premium for Sherwin-Williams' dominant market position and strong brand, but the valuation leaves little room for error.
SHW is a good stock to buy for long-term investors seeking a quality market leader with a strong competitive moat and consistent cash flows. The analyst consensus is Buy with an average target of $378.90, implying 14.4% upside from the current price of $331.32. However, the stock trades at a trailing P/E of 31.22x, which is above the industry average, and carries high debt (D/E 3.16). For risk-averse investors, waiting for a pullback to $300 (trailing P/E ~24x) would provide a better margin of safety. Overall, it is a buy on dips for those with a 3-5 year horizon.
SHW is best suited for long-term investment (3-5 years or more) due to its stable business model, consistent dividend growth (47 consecutive annual increases), and strong free cash flow. The stock's beta of 1.1 indicates moderate market correlation, but its 1-year underperformance (-2.52% vs S&P 500 +18.35%) and recent downtrend make it less attractive for short-term trading. Short-term traders may find opportunities around earnings announcements or housing data releases, but the stock's low volatility and high quality favor a buy-and-hold approach. A minimum holding period of 3 years is recommended to ride out cyclical downturns.